{"id":7210,"date":"2023-03-23T10:49:01","date_gmt":"2023-03-23T10:49:01","guid":{"rendered":"https:\/\/www.shs-capital.eu\/?p=7210"},"modified":"2025-09-02T07:42:26","modified_gmt":"2025-09-02T06:42:26","slug":"us-launch-for-sis-super-shock-balloon-opn-nc","status":"publish","type":"post","link":"https:\/\/www.shs-capital.eu\/us-launch-for-sis-super-shock-balloon-opn-nc\/","title":{"rendered":"US launch for SIS super shock balloon OPN NC\u00ae"},"content":{"rendered":"<p>SIS Medical AG (Swiss Interventional Systems), a leading global developer, manufacturer and distributor of high-quality, high-performance interventional cardiology products, announces the US launch of its flagship product, the OPN NC\u00ae PTCA Dilatation Catheter with TWIN-Wall Technology. The product expands treatment options with high performance and safety, providing success rates where other balloons fail.<\/p>\n<p>The OPN NC\u00ae catheter features a unique TWIN-Wall design developed by SIS Medical AG, offering very high pressure resistance with a nominal burst pressure of 35 atm. These performance features allow perfect preparation of challenging lesions prior to stenting without over-dilating the blood vessel. The device can also be used for post-dilatation of under expanded stents. The OPN NC\u00ae coronary balloon is the only super-high pressure 35 atm coronary balloon to receive 510(k) clearance from the U.S. Food &amp; Drug Administration.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SIS Medical AG (Swiss Interventional Systems), a leading global developer, manufacturer and distributor of high-quality, high-performance interventional cardiology products, announces the US launch of its flagship product, the OPN NC\u00ae PTCA Dilatation Catheter with TWIN-Wall Technology. The product expands treatment options with high performance and safety, providing success rates where other balloons fail. The OPN [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7212,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[90],"tags":[],"class_list":["post-7210","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-shs-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/posts\/7210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/comments?post=7210"}],"version-history":[{"count":0,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/posts\/7210\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/media\/7212"}],"wp:attachment":[{"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/media?parent=7210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/categories?post=7210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.shs-capital.eu\/wp-json\/wp\/v2\/tags?post=7210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}